GV 2019 Gp, LLC is 10% Owner at Prime Medicine, Inc. (PRME). They have made 6 open-market trades across 1 company since 2023, most recently 2026-07-28.
CIK 0001845038
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRME | 10,302,748 | $35.8M |
| DBTX | 819,631 | $4.0M |
| LIFE | 200 | $7K |
| Total | $39.8M |
Shares reported on the most recent Form 4, priced at the 2026-07-23 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 17% | — |
| Avg Move | +29.6% | +73.9% | — |
| Scored | 6 | 6 | 2 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LIFE | SELL | 2026-07-27 | 2026-07-29 | $19.25 | $6.1M | +61.3% | +92.0% | — |
| LIFE | SELL | 2026-07-23 | 2026-07-27 | $19.01 | $1.6M | +66.2% | +117.8% | — |
| LIFE | SELL | 2026-07-21 | 2026-07-23 | $19.17 | $1.4M | +43.2% | +90.1% | — |
| LIFE | SELL | 2026-07-17 | 2026-07-21 | $18.77 | $730K | +7.5% | +76.1% | — |
| LIFE | SELL | 2026-07-15 | 2026-07-17 | $19.47 | $1.8M | +7.1% | +89.7% | +109.7% |
| LIFE | SELL | 2026-05-14 | 2026-05-18 | $23.45 | $3.5M | -7.8% | -22.1% | +71.2% |
| PRME | SELL · 10b5-1 | 2023-06-09 | 2023-06-13 | $14.73 | $934K | -1.1% | -1.2% | -14.1% |
| PRME | SELL · 10b5-1 | 2023-05-26 | 2023-05-31 | $13.70 | $806K | +6.6% | +6.2% | -3.3% |
| PRME | SELL · 10b5-1 | 2023-05-12 | 2023-05-16 | $12.74 | $4.7M | +8.8% | +19.4% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.